Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Narcolepsy01:07

Narcolepsy

Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
Sleep-Wake Cycles01:24

Sleep-Wake Cycles

Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and  rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Insomnia01:27

Insomnia

Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of pain on memory: a study in chronic low back pain and migraine patients.

Brain communications·2026
Same author

Migraine-related disability according to headache frequency subclassifications: A systematic review and meta-analysis.

Cephalalgia : an international journal of headache·2025
Same author

Hallmarks of primary headache: part 3 - cluster headache.

The journal of headache and pain·2025
Same author

Real-World Experience of Erenumab in Patients with Migraine in Germany: The SPECTRE Study.

Pain and therapy·2024
Same author

Erenumab escalation in migraine - double dose without additional benefit - a retrospective experience.

Acta neurologica Belgica·2024
Same author

Persistent effectiveness of CGRP antibody therapy in migraine and comorbid medication overuse or medication overuse headache - a retrospective real-world analysis.

The journal of headache and pain·2024
Same journal

An overview of the safety and efficacy of sphenopalatine ganglion stimulation for the treatment of chronic cluster headache.

Expert review of neurotherapeutics·2026
Same journal

Multiomics and proteomic insights into Alzheimer's disease biology in Down syndrome.

Expert review of neurotherapeutics·2026
Same journal

Remote deep brain stimulation programming in childhood dystonia: opportunities, challenges, and future directions.

Expert review of neurotherapeutics·2026
Same journal

The differential diagnosis of astrocytic neoplasms and its impact on treatment and prognosis.

Expert review of neurotherapeutics·2026
Same journal

Corticosteroids in withdrawal therapy following medication-overuse headache: a systematic review.

Expert review of neurotherapeutics·2026
Same journal

Clinical efficacy of lacosamide in neuropathic pain: a systematic review of randomized controlled trials.

Expert review of neurotherapeutics·2026
See all related articles

Related Experiment Video

Updated: Jun 8, 2026

Minimally Invasive Surgical Decompression of Occipital Nerves
04:06

Minimally Invasive Surgical Decompression of Occipital Nerves

Published on: September 13, 2024

Hypnic headache.

Mark Obermann1, Dagny Holle

  • 1Department of Neurology, University of Duisburg-Essen, Hufelandstrasse 55, Essen, Germany. mark.obermann@uni-due.de

Expert Review of Neurotherapeutics
|September 16, 2010
PubMed
Summary
This summary is machine-generated.

Hypnic headache, a rare sleep-related disorder in older adults, remains poorly understood. Research suggests hypothalamic dysfunction may be involved, with caffeine, lithium, and indomethacin showing potential therapeutic benefits.

More Related Videos

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

Related Experiment Videos

Last Updated: Jun 8, 2026

Minimally Invasive Surgical Decompression of Occipital Nerves
04:06

Minimally Invasive Surgical Decompression of Occipital Nerves

Published on: September 13, 2024

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

Area of Science:

  • Neurology
  • Sleep Medicine

Background:

  • Hypnic headache is a rare primary headache disorder exclusively affecting patients over 50 during sleep.
  • Fewer than 174 cases are documented, leading to limited understanding of its clinical features, pathophysiology, and treatments.

Purpose of the Study:

  • To consolidate current knowledge on hypnic headache, focusing on its pathophysiology and therapeutic strategies.
  • To address the ongoing debate regarding its association with sleep stages and potential underlying mechanisms.

Main Methods:

  • Literature review of reported cases and clinical studies on hypnic headache.
  • Analysis of proposed pathophysiological mechanisms, including hypothalamic dysfunction.
  • Compilation of documented treatment options, both acute and prophylactic.

Main Results:

  • Recent studies contradict an association with REM sleep.
  • Hypothalamic dysfunction is considered a significant potential pathophysiological mechanism.
  • Caffeine is a common acute and prophylactic treatment; lithium, indomethacin, and melatonin are noted as potent options, with other drugs showing efficacy in isolated reports.

Conclusions:

  • Hypnic headache pathophysiology is not fully elucidated, but hypothalamic dysfunction is a key area of investigation.
  • Effective treatments include caffeine, lithium, indomethacin, and melatonin, though further research is needed for comprehensive management strategies.